endometrial + cervical Flashcards
epi endometrial
54k cases annual, 10k deaths; estrogen driven tumor, obesity is increasing rate in developed world. DM also risk factor
genetics of endometrial
HNPCC, often the sentinel event for HNPCC. at MSKCC, do MMR IHC on tumor if <60y. endometrial has aberrency in PI3K/AKT
endometrial cancer staging
FIGO 2009: stage I- confined A50%, II-invading cervical stroma; III-regional spread; IV-distant
most common endometrial cancer
endometrioid: FIGO grade 1,2,3
serous carcinoma endometrium
automatically high risk
adjuvant therapy for endometriod endometrial stage I
EBRT does not improve survival but reduces QOL. if higher risk, then give brachytherapy to spare the toxicities
risk factor for endometrial
age, grade 2/3, LVI, outer 1/3 myometrial invasion
chemotherapy for endometrial?
high risk stage I- no OS benefit with chemo shown compared to EBRT
stage III/IV with no residual endometrial, adjuvant therapy?
OS benefit of chemotherapy carbo/taxol. differences not large, but real. less toxic than pelvic RT
hormones for endometrial cancer
response rate to hormones but 10-30% but duration of response 1-3month. its an option but short benefit. Menace approved!
initial chemo for metastatic endometrial
TAP (cis/dox/taxol) v. dox/cis–> 2 months OS of the combination. However then compared to taxol/carbo–>same OS. Taxol/carbo is now standard.
cervical cancer epi
12k annual USA, 4k deaths. almost all HPV+ 16,18.
cervical screening guideliens
start at 21, every 3 years, if get PCR the can test every 5 years
cervical ca types
75% SCC, 20% adeno
cervial ca staging
I- confined, II-beyond but not to wall or lower third of vagina; IIb- with invasion parametrial (NOT operable). ALL curable except IVb (distant met).